Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
2019 · Journal of the National Comprehensive Cancer Network · 1,548 citations
https://doi.org/10.6004/jnccn.2019.0023
J
Joshua M. Lang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
393
Papers
8.5K
Citations
42
h-index
96
i10-index
Joshua M. Lang is an academic researcher from University of Wisconsin–Madison. The author has contributed to research in topics: Prostate Cancer Treatment and Research & Cancer Genomics and Diagnostics & Cancer Cells and Metastasis. The author has an h-index of 42, co-authored 335 publications.
ORCID: 0000-0002-0943-8872Papers by this author
worksNCCN Guidelines Insights: Prostate Cancer, Version 1.2021
2021 · Journal of the National Comprehensive Cancer Network · 522 citations
https://doi.org/10.6004/jnccn.2021.0008
Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology
2023 · Journal of the National Comprehensive Cancer Network · 509 citations
https://doi.org/10.6004/jnccn.2023.0050
Platelets Promote Metastasis via Binding Tumor CD97 Leading to Bidirectional Signaling that Coordinates Transendothelial Migration
2018 · Cell Reports · 153 citations
https://doi.org/10.1016/j.celrep.2018.03.092
Reversible epigenetic alterations regulate class I HLA loss in prostate cancer
2022 · Communications Biology · 45 citations
https://doi.org/10.1038/s42003-022-03843-6
ARV-766, a proteolysis targeting chimera (PROTAC) androgen receptor (AR) degrader, in metastatic castration-resistant prostate cancer (mCRPC): Initial results of a phase 1/2 study.
2024 · Journal of Clinical Oncology · 29 citations
https://doi.org/10.1200/jco.2024.42.16_suppl.5011
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat